JAVIER
ESCANED BARBOSA
Profesor asociado de Ciencias de la Salud
Medisch Spectrum Twente
Enschede, HolandaPublicaciones en colaboración con investigadores/as de Medisch Spectrum Twente (18)
2023
-
Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 13, pp. e1099-e1107
-
Morphological characteristics of lesions with thin cap fibroatheroma-a substudy from the COMBINE (OCT-FFR) trial
European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 5, pp. 687-693
2022
-
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design
American Heart Journal, Vol. 246, pp. 32-43
-
Prediction of All-Cause Mortality Following Percutaneous Coronary Intervention in Bifurcation Lesions Using Machine Learning Algorithms
Journal of Personalized Medicine, Vol. 12, Núm. 6
-
Sustained Safety and Performance of a Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Long-Term Data of the BIOSOLVE-II First-in-Man Trial at 5 Years
Cardiovascular Revascularization Medicine, Vol. 38, pp. 106-110
-
Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights from the COMBINE OCT-FFR Trial
Circulation: Cardiovascular Interventions, Vol. 15, Núm. 5, pp. E011728
2021
-
Impact of Endothelial Shear Stress on Absorption Process of Resorbable Magnesium Scaffold: A BIOSOLVE-II Substudy
Cardiovascular Revascularization Medicine, Vol. 29, pp. 9-15
-
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial
European heart journal, Vol. 42, Núm. 45, pp. 4671-4679
-
Transient ST-elevation myocardial infarction versus persistent ST-elevation myocardial infarction. An appraisal of patient characteristics and functional outcome
International Journal of Cardiology, Vol. 336, pp. 22-28
2019
-
Evaluation of Microvascular Injury in Revascularized Patients With ST-Segment-Elevation Myocardial Infarction Treated With Ticagrelor Versus Prasugrel: The REDUCE-MVI Trial
Circulation, Vol. 139, Núm. 5, pp. 636-646
-
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study
Cardiovascular Revascularization Medicine, Vol. 20, Núm. 5, pp. 392-398
-
Impact of procedural characteristics on coronary vessel wall healing following implantation of second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary artery lesions: An optical coherence tomography analysis
European Heart Journal Cardiovascular Imaging, Vol. 20, Núm. 8, pp. 916-924
-
Serial 3-Dimensional Optical Coherence Tomography Assessment of Jailed Side-Branch by Second-Generation Drug-Eluting Absorbable Metal Scaffold (from the BIOSOLVE-II Trial)
American Journal of Cardiology, Vol. 123, Núm. 7, pp. 1044-1051
-
Temporal Changes in Coronary Hyperemic and Resting Hemodynamic Indices in Nonculprit Vessels of Patients with ST-Segment Elevation Myocardial Infarction
JAMA Cardiology, Vol. 4, Núm. 8, pp. 736-744
2018
-
In vivo serial invasive imaging of the second-generation drug-eluting absorbable metal scaffold (Magmaris — DREAMS 2G) in de novo coronary lesions: Insights from the BIOSOLVE-II First-In-Man Trial
International Journal of Cardiology, Vol. 255, pp. 22-28
2016
-
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial
The Lancet, Vol. 387, Núm. 10013, pp. 31-39
-
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial
European Heart Journal, Vol. 37, Núm. 35, pp. 2701-2709
2015
-
Fractional flow reserve and coronary bifurcation anatomy: A novel quantitative model to assess and report the stenosis severity of bifurcation lesions
JACC: Cardiovascular Interventions, Vol. 8, Núm. 4, pp. 564-574